These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Estrogen and progesterone hormonal receptors in meningioma. Results and comments apropos of 26 cases]. Jan M; Picaper G Neurochirurgie; 1984; 30(6):373-7. PubMed ID: 6527709 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Brandis A; Mirzai S; Tatagiba M; Walter GF; Samii M; Ostertag H Neurosurgery; 1993 Aug; 33(2):212-7; discussion 217-8. PubMed ID: 8367042 [TBL] [Abstract][Full Text] [Related]
28. Rapid growth of a meningioma during pregnancy: relationship with estrogen and progesterone receptors--case report. Saitoh Y; Oku Y; Izumoto S; Go J Neurol Med Chir (Tokyo); 1989 May; 29(5):440-3. PubMed ID: 2477748 [TBL] [Abstract][Full Text] [Related]
29. Assay of oestrogen and progestin receptors in human meningioma cytosols using immunological methods. Blankenstein MA; van der Meulen-Dijk C; Thijssen JH Clin Chim Acta; 1987 Jun; 165(2-3):189-95. PubMed ID: 3308181 [TBL] [Abstract][Full Text] [Related]
30. Steroid hormone receptors in human meningiomas, gliomas and brain metastases. Poisson M; Pertuiset BF; Hauw JJ; Philippon J; Buge A; Moguilewsky M; Philibert D J Neurooncol; 1983; 1(3):179-89. PubMed ID: 6088714 [TBL] [Abstract][Full Text] [Related]
31. Expression of PDGF, PDGF-receptor, EGF-receptor and sex hormone receptors on meningioma. Kuratsu JI; Seto H; Kochi M; Ushio Y Acta Neurochir (Wien); 1994; 131(3-4):289-93. PubMed ID: 7754837 [TBL] [Abstract][Full Text] [Related]
36. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas. Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792 [TBL] [Abstract][Full Text] [Related]
37. Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas. Piantelli M; Rinelli A; Macrì E; Maggiano N; Larocca LM; Scerrati M; Roselli R; Iacoangeli M; Scambia G; Capelli A Cancer; 1993 Jan; 71(1):193-8. PubMed ID: 8416715 [TBL] [Abstract][Full Text] [Related]
38. Estrogen and progestin receptors in intracranial tumors. Punnonen R; Kuurne T Horm Res; 1987; 27(2):74-7. PubMed ID: 3653847 [TBL] [Abstract][Full Text] [Related]
39. The impact of progesterone receptor expression on relapse in the long-term clinical course of 93 benign meningiomas. Strik HM; Strobelt I; Pietsch-Breitfeld B; Iglesias-Rozas JR; Will B; Meyermann R In Vivo; 2002; 16(4):265-70. PubMed ID: 12224136 [TBL] [Abstract][Full Text] [Related]
40. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]